title: Relative sialylation and fucosylation of synovial and plasma fibronectins in relation to the progression and activity of rheumatoid arthritis.
abstract: The expressions of terminal sugars in synovial and plasma fibronectins were studied in relation to rheumatoid arthritis (RA) progression defined according to the early, established and late radiological changes in the patients' hands. The relative amounts of sialic acid and fucose were analyzed by lectin-ELISA using appropriate sialic acid-linked alpha2-3 (Maackia amurensis) and alpha2-6 (Sambucus nigra) lectins as well as fucose-linked alpha1-6 (Aleuria aurantia), alpha1-2 (Ulex europaeus), and alpha1-3 (Tetragonolobus purpureus). In the early RA group, the synovial fibronectin reactivities were the lowest with the all lectins used. In the established and late groups, relative sialylation and fucosylation significantly increased. However, sialylation negligibly decreased, whereas fucosylation remained at nearly the same level in the late group. Moreover, the expression of alpha1-6-linked fucose was found to be related to disease activity. In contrast, plasma fibronectin reactivity with lectins showed different dynamic alterations. In the early RA group, the reactivity of fibronectin with the lectins used was similar to that of healthy individuals, whereas it increased significantly in the established RA group compared with the early and normal plasma groups. In the late RA group it decreased to a level similar to that of the normal group. The lower expressions of terminal sugars in synovial fibronectin were mainly associated with the early degenerative processes of RA. In conclusion, such alterations may be applicable as a stage-specific marker for diagnosis and therapy of RA patients. The higher expression of terminal sugars in fibronectin could be associated with repair and adaptation processes in longstanding disease.
authors.affiliation: Department of Chemistry and Immunochemistry, Wrocław Medical University, Bujwida 44a, 50-345, Wrocław, Poland.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Przybysz
authors.forename: Dorota
authors.initials: D
authors.lastname: Maszczak
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Borysewicz
authors.forename: Jacek
authors.initials: J
authors.lastname: Szechiński
authors.forename: Iwona
authors.initials: I
authors.lastname: Katnik-Prastowska
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000175:diagnosis / Q000473:pathology*; D002241:Carbohydrates / Q000737:chemistry; D016022:Case-Control Studies; D018450:Disease Progression; D005260:Female; D005353:Fibronectins / Q000096:biosynthesis* / Q000097:blood* / Q000737:chemistry; D005643:Fucose / Q000737:chemistry; D005786:Gene Expression Regulation; D006801:Humans; D037102:Lectins / Q000737:chemistry; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D012794:Sialic Acids / Q000378:metabolism*; D013582:Synovial Fluid / Q000378:metabolism
chemical_list: D002241:Carbohydrates; D005353:Fibronectins; D037102:Lectins; D012794:Sialic Acids; D005643:Fucose